drugset / Trial / NCT05659602
A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the preliminary efficacy and safety of HH-120 nasal spray in the treatment of asymptomatic or mild COVID-19.
Timeline
- Start
- 2022-07-09
- Primary completion
- 2023-01-03
- Completion
- 2023-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HH-120 | Protein / enzyme biologic | — | Intranasal |